Molecular cross-talk via extracellular vesicles for the characterization of young subjects with type 1 diabetes unravels new potential markers of insulin resistance and double diabetes
- Diabetol Metab Syndr. 2025 Dec 10;18(1):16. doi: 10.1186/s13098-025-02042-7.
- 1. Department of Innovative Technologies in Medicine and Dentistry, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
- 2. Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
- 3. UOSVD Paediatrics Della Murgia Fabio Perinei Hospital, Altamura (BA), 70022, Italy.
- 4. Department of Medicine and Aging Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
- 5. Department of Humanities Law and Economics, Leonardo da Vinci University, Torrevecchia Teatina (CH), 66010, Italy.
- 6. Department of Maternal and Child Health UOSD Regional Center of Paediatric Diabetology, Chieti Hospital, Chieti, 66100, Italy.
- 7. Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
- 8. Department of Science, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
- 9. Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy. [email protected].
- 10. Department of Science, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy. [email protected].
Background: Insulin Resistance (IR) is commonly calculated using a simple mathematical formula, the eGDR (estimated Glucose Disposal Rate), but in the paediatric type I diabetes (T1DM) population this value has provided contrasting information. We aimed to provide a clearer metabolic "fingerprint" in children with "double diabetes", focusing on the molecular cross-talk mediated by extracellular vesicles (EVs).
Methods: Paediatric patients were classified based on the eGDR value in: insulin-resistant (T1DM+, eGDR < 8 mg/Kg/min, n = 29) and non-insulin-resistant (T1DM-, eGDR > 8 mg/Kg/min, n = 35). Venous blood collected from them, and 30 healthy controls was used to obtain dried blood spots (DBS) for AAs and ACs analysis by FIA-MS/MS and for EV by a patented flow cytometry method. Then, EVs were subjected to shotgun proteomics analysis by LC-MS/MS.
Results: Our data showed that T1DM + EVs were packaged with proteins involved in fatty acid metabolism suppression through STAT3 inhibition and related to possible liver damage. ACs on DBS samples corroborated these data, demonstrating a significant increase in oleoylcarnitine (C18:1), linoleoylcarnitine (C18:2), and myristoylcarnitine (C14) in T1DM+. The combination of clinical and metabolic data led to the identification of a statistical model with an out-of-bag error of 0.115%, demonstrating that palmitoleoylcarnitine (C16:1) and C18:1 are the metabolites that best distinguish children with T1DM + from T1DM- ones. C16:1 correlated significantly with eGDR (p = 0.0023).
Conclusions: Combined "omics" approach allowed us to identify a new metabolic "photograph" in a complex context involving diabetes complications related to Obesity and IR in a paediatric population that is not yet fully characterized, identifying EVs as well-organized and functionalized shuttles.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Endogenous Metabolite